EPSTEIN-BARR VIRUS-DRIVEN DISEASES: A MULTINATIONAL, MULTICOHORT, OPEN-LABEL PHASE 2 STUDY TO ASSESS THE EFFICACY AND SAFETY OF TABELECLEUCEL USING AN ADAPTIVE STUDY DESIGN
2021
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI